Emily Pimblett Eliem Therapeutics, Inc. (ELYM) insider trading activity
Emily Pimblett is SVP, Finance & CAO of Eliem Therapeutics, Inc.. Currently has a direct ownership of 18,888 shares of ELYM, which is worth approximately $77,629. The most recent transaction as insider was on Jun 20, 2025, when has been sold 1,242 shares (Common Stock) at a price of $1.24 per share, resulting in proceeds of $1,540. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18.9K
24.84%
3M change
403.01%
12M change
Total Value Held
$77,629
Emily Pimblett Transaction History
EP
Emily Pimblett
SVP, Finance & CAO
Wilmington, DE